Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rafla

Cancer

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer|February 1, 1971
Major surgery after radical radiotherapy. Indications and complicationsS Rafla
Cancer|October 1, 1970
Submaxillary gland tumorsS Rafla
Cancer|July 1, 1977
Malignant parotid tumors: natural history and treatmentS Rafla
Cancer|January 1, 1970
Renal cell carcinoma. Natural history and results of treatmentS Rafla
Cancer|March 1, 1978
Changes in cell-mediated immunity in patients undergoing radiotherapyS Rafla, S J Yang, F Meleka
Cancer|March 1, 1993
Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease. The Cancer and Leukemia Group BR Mir, J Anderson, J Strauchen, et al.
Cancer|November 1, 1982
Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experienceG G Cornwell, T F Pajak, S Kochwa, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer|February 1, 1971
Major surgery after radical radiotherapy. Indications and complicationsS Rafla
Cancer|October 1, 1970
Submaxillary gland tumorsS Rafla
Cancer|July 1, 1977
Malignant parotid tumors: natural history and treatmentS Rafla
Cancer|January 1, 1970
Renal cell carcinoma. Natural history and results of treatmentS Rafla
Cancer|March 1, 1978
Changes in cell-mediated immunity in patients undergoing radiotherapyS Rafla, S J Yang, F Meleka
Cancer|March 1, 1993
Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease. The Cancer and Leukemia Group BR Mir, J Anderson, J Strauchen, et al.
Cancer|November 1, 1982
Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experienceG G Cornwell, T F Pajak, S Kochwa, et al.
Pageof 1